versión impresa ISSN 0004-282X
Arq. Neuro-Psiquiatr. vol.70 no.4 São Paulo abr. 2012
Ataxia cerebelar como manifestação inicial da doença de Alexander
Sheyla Ariêh de Souza RezendeI; Maurício FernandesI; Renato Puppi MunhozI; Salmo RaskinII; Arthur Oscar SchelpIII; Marjo S. van der KnaapIV; Hélio A. G. TeiveI
IMovement Disorders Unit, Neurology Service, Internal Medicine Department, Hospital de Clínicas, Federal University of Paraná, Curitiba PR, Brazil
IIGenetika Laboratory, Curitiba PR, Brazil
IIINeurology Department, Botucatu Medical School, São Paulo State University, São Paulo SP, Brazil
IVVU University Medical Center, Amsterdam, the Netherlands
Alexander's disease (AD) is a rare neurodegenerative disorder, classified as a leukodystrophy and characterized by macrocephaly, psychomotor regression, spasticity, ataxia, and seizures1. Neuropathologically, it is diagnosed by the presence of perivascular, periventricular, brainstem, and cerebellar eosinophylic intra-astrocytic cytoplasmic inclusions, which are called Rosenthal fibres1. AD is caused by mutations in the gene encoding glial fibrillary acidic protein (GFAP) on chromosome 17qq21, with an autosomal dominant inheritance1-3. The aim was to describe a female young patient with progressive cerebellar ataxia as the first manifestation of AD.
A 13-year-old female was investigated because of a four-year history of progressive gait disorder and incoordination. These progressive symptoms were accompanied by dysarthria, poor balance, and poor academic performance. Neurological examination showed mild cognitive impairment (MMSE=20), dysarthria, horizontal and vertical gaze-evoked nystagmus, and gait ataxia. Brain magnetic resonance image (MRI) showed bilateral symmetric leukoencephalopathy, with frontal preponderance, without signal changes in the cerebellum (Figure). The patient was evaluated in another neurological service and she had an extensive work up, including anti-gliadin, anti-peroxidase, anti-thyroglobulin, and anti-GAD antibodies, spinal cord MRI, electroneuromyography, sural nerve biopsy, and tests for inherited metabolic disorders, including very long-chain fatty acid, arysulfatase A and beta-galactosidase activity test. These were all normal. Re-evaluation of brain MRI suggested the diagnosis of AD. Molecular genetic test confirmed a heterozygous mutation (D157N) in the exons 2 and 8 (M4151) in the GFAP gene. The patien's mother was diagnosed with multiple sclerosis, treated with steroids and interferon. She had cerebellar ataxia and spasticity in the legs, and the brain MRI showed white matter abnormalities predominantly in both frontal lobes. She has a heterozygous mutation (M4151) in the exon 8 in the GFAP gene, confirming that she also had AD.
AD is divided into three different forms: typical infantile form, with onset before two years of age and rapidly lethal course; juvenile form, with onset between 2 and 12 years of age, with slower progression; adult-onset form, with onset after the age of 12 years, or during adulthood, with predominant involvement of the brainstem, with bulbar or pseudobulbar symptoms, such as dysarthria, dysphagia, pyramidal signs, palatal myoclonus, and cerebellar ataxia1.
MRI in early onset of AD is characterized by supratentorial periventricular white matter abnormalities, particularly in the frontal lobes. In adult-onset cases, MRI is often characterized by atrophy and signal abnormalities in the medulla oblongata and upper spinal cord1,3. Juvenile AD represents 17.8 to 24.2% of the total cases, and it is the least common form of the disease. It represents a continuum between the infantile form, with cortical and subcortical signs, and the adult one with cerebellar and brainstem signs1,4. Yoshida et al.4 proposed a new clinical guideline for diagnosis of AD, including AD type 1, or cerebral AD, type 2, or bulbospinal AD, and type 3 or intermediate form of AD. This should be included in the differential diagnosis of cerebellar ataxia, with early and late onsets, in sporadic and hereditary cases1,5. Delnooz et al.5 described two sibs with AD, hereditary late-onset ataxia, and only minimal white matter changes. The phenotypic spectrum of AD was enlarged after the definition of the molecular genetic diagnosis with GFAP analysis1-5.
1. Pareyson D, Fancellu R, Mariotti C, et al. Adult-onset Alexander disease: a series of eleven unrelated cases with review of the literature. Brain 2008;131:2321-2331. [ Links ]
2. Li R, Johnson AB, Salomons G, et al. Glial fibrillary acid protein mutation in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol 2005;57:310-326. [ Links ]
3. van der Knaap MS, Naidu S, Breiter SN, et al. Alexander disease: diagnosis with MR imaging. Am J Neuroradiol 2001;22:541-552. [ Links ]
4. Yoshida T, Sasaki M, Yoshida M, et al. Nationwide survey of Alexander disease in Japan and proposed new guidelines for diagnosis. J Neuro 2011; May 1. [Epub ahead of print] [ Links ].
5. Delnooz CC, Schelhaas JH, van de Warrenburg BP, de Graaf RJ, Salomons GS. Alexander disease causing hereditary late-onset ataxia with only minimal white mater changes: a report of two sibs. Mov Disord 2008;23:1613-1615. [ Links ]
Hélio A. G. Teive
Rua General Carneiro 1103/102
80060-150 Curitiba PR - Brasil
Received 13 November 2011
Accepted 24 November 2011
Conflict of interest:
There is no conflict of interest to declare.